Currency in USD
Earnings estimate | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|
No. of analysts | 5 | 5 | 5 | 5 |
Avg. Estimate | 2.15 | 2.29 | 10.56 | 12 |
Low estimate | 2.02 | 2.03 | 10.25 | 11.45 |
High estimate | 2.29 | 2.49 | 10.96 | 12.38 |
Year ago EPS | 3.34 | 3 | 11.78 | 10.56 |
Revenue estimate | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|
No. of analysts | 5 | 5 | 5 | 5 |
Avg. Estimate | 619.09M | 660.98M | 2.69B | 2.83B |
Low estimate | 612.1M | 645.1M | 2.68B | 2.8B |
High estimate | 629.16M | 676.7M | 2.71B | 2.86B |
Year ago sales | 676.84M | 697.96M | 2.67B | 2.69B |
Sales growth (year/est) | -8.50% | -5.30% | 0.60% | 5.20% |
Earnings history | 30/03/2023 | 29/06/2023 | 29/09/2023 | 30/12/2023 |
---|
Est. EPS | 3.54 | 2.68 | 2.78 | 2.82 |
Actual EPS | 3.34 | 3 | 2.33 | 3.1 |
Difference | -0.2 | 0.32 | -0.45 | 0.28 |
Surprise % | -5.60% | 11.90% | -16.20% | 9.90% |
EPS trend | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|
Current estimate | 2.15 | 2.29 | 10.56 | 12 |
7 days ago | 2.15 | 2.29 | 10.56 | 12 |
30 days ago | 2.66 | 2.49 | 10.7 | 12.15 |
60 days ago | 2.66 | 2.49 | 10.7 | 12.15 |
90 days ago | 3.28 | 2.92 | 11.57 | 13.16 |
EPS revisions | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|
Up last 7 days | N/A | N/A | N/A | N/A |
Up last 30 days | N/A | N/A | N/A | N/A |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | N/A | N/A | N/A | N/A |
Growth estimates | BIO | Industry | Sector(s) | S&P 500 |
---|
Current qtr. | -35.60% | N/A | N/A | N/A |
Next qtr. | -23.70% | N/A | N/A | N/A |
Current year | -10.40% | N/A | N/A | N/A |
Next year | 13.60% | N/A | N/A | N/A |
Next 5 years (per annum) | 17.80% | N/A | N/A | N/A |
Past 5 years (per annum) | 13.82% | N/A | N/A | N/A |